Skip to main content
. 2008 Mar 3;153(Suppl 1):S112–S119. doi: 10.1038/sj.bjp.0707654

Table 2. Phase IIb programme STAIR II criteria.

• Route of administration
• Dose range
• Time from stroke onset to initiation of treatment
• Pharmacokinetic profile
• Side effects and their frequency
• Drug interactions
• Drug distribution to the proposed site of action
• Refinement and identification of the target population
• Established therapeutic activity through evaluation of clinical and/or surrogate markers